Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001000773 | SCV001157826 | likely pathogenic | Hereditary factor VIII deficiency disease | 2018-08-22 | criteria provided, single submitter | clinical testing | The F8 c.377A>G; p.Lys126Arg variant, also known as K107R in the traditional nomenclature, is reported in the literature in at least one individual affected with hemophilia A (Rydz 2013). This variant is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. Additionally, another variant at this codon (c.377A>C; p.Lys126Thr) has been reported in individuals with severe hemophilia A (Markoff 2009, see link to Factor VIII database). The lysine at codon 126 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Based on available information, the p.Lys126Arg variant is considered to be likely pathogenic. References: Link to Factor VIII database: http://www.factorviii-db.org/ Markoff A et al. Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function. Haemophilia. 2009 Jul;15(4):932-41. Rydz N et al. The Canadian National Program for hemophilia mutation testing" database: a ten-year review. Am J Hematol. 2013 Dec;88(12):1030-4." |